SEEL stock forecast
Our latest prediction for Seelos Therapeutics, Inc.'s stock price was made on the Feb. 13, 2020 when the stock price was at 0.82$.
In the short term (2weeks), SEEL's stock price should outperform the market by 6.20%. During that period the price should oscillate between -12.54% and +25.21%.
In the medium term (3months), SEEL's stock price should outperform the market by 18.14%. During that period the price should oscillate between -46.13% and +74.17%.Get email alerts
About Seelos Therapeutics, Inc.
Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It focuses on development and advancement of novel therapeutics to address unmet medical needs for the benefit of patients with central nervous system disorders. Its portfolio includes late-stage clinical assets targeting psychiatric and movement disorders. The company is headquartered in New York, NY.
At the moment the company generates 6M USD in revenues.
On its last earning announcement, the company reported a loss of -13.65$ per share.
The book value per share is 0.28$
Three months stock forecastFeb. 13, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|